Altiris Therapeutics

company

About

Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer.

  • 501 - 1000

Details

Last Funding Type
Series B
Last Funding Money Raised
$35M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2005
Number Of Employee
501 - 1000
Operating Status
Active

Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. The company offers CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection.

Altiris Therapeutics was founded in 2005 and is based in Atlanta, Georgia.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$35M
Altiris Therapeutics has raised a total of $35M in funding over 2 rounds. Their latest funding was raised on Oct 9, 2007 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 9, 2007 Series B $35M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Altiris Therapeutics is funded by 2 investors. Centrosome Ventures and Georgia Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Centrosome Ventures Series B
Georgia Venture Partners Series B